ABSTRACT
Two novel unsymmetrical binucleating aroylhydrazonic ligands and four dicopper(II) complexes carrying fluorescent benzopyranothiophene (BPT) or boron dipyrromethene (BODIPY) entities were synthesized and fully characterized. Complex 1, derived from the BPT-containing ligand H3L1, had its crystal structure elucidated through X-ray diffraction measurements. The absorption and fluorescence profiles of all the compounds obtained were discussed. Additionally, the stability of the ligands and complexes was monitored by UV-vis spectroscopy in DMSO and biologically relevant media. All the compounds showed moderate to high cytotoxicity towards the triple negative human breast cancer cell line MDA-MB-231. BPT derivatives were the most cytotoxic, specially H3L1, reaching an IC50 value up to the nanomolar range. Finally, fluorescence microscopy imaging studies employing mitochondria- and nucleus-staining dyes showed that the BODIPY-carrying ligand H3L2 was highly cell permeant and suggested that the compound preferentially accumulates in the mitochondria.
Subject(s)
Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Boron Compounds/chemistry , Copper/chemistry , Thiophenes/pharmacology , Antineoplastic Agents/metabolism , Cell Line, Tumor , Female , Humans , Microscopy, Fluorescence , Molecular Structure , Thiophenes/chemistry , Triple Negative Breast NeoplasmsABSTRACT
Misfolded prion protein (PrPSc) is known for its role in fatal neurodegenerative conditions, such as Creutzfeldt-Jakob disease. PrP fragments and their mutants represent important tools in the investigation of the neurotoxic mechanisms and in the evaluation of new compounds that can interfere with the processes involved in neuronal death. Metal-catalyzed oxidation of PrP has been implicated as a trigger for the conformational changes in protein structure, which, in turn, lead to misfolding. Targeting redox-active biometals copper and iron is relevant in the context of protection against the oxidation of biomolecules and the generation of oxidative stress, observed in several conditions and considered an event that might promote sporadic prion diseases as well as other neurodegenerative disorders. In this context, ortho-pyridine aroylhydrazones are of interest, as they can act as moderate tridentate ligands towards divalent metal ions such as copper(II). In the present work, we explore the potentiality of this chemical class as peptide protecting agents against the deleterious metal-catalyzed oxidation in the M112A mutant fragment of human PrP, which mimics relevant structural features that may play an important role in the neurotoxicity observed in prion pathologies. The compounds inhere studied, especially HPCFur, showed an improved stability in aqueous solution compared to our patented lead hydrazone INHHQ, displaying a very interesting protective effect toward the oxidation of methionine and histidine, processes that are related to both physiological and pathological aging.
Subject(s)
Chelating Agents/chemistry , Copper/chemistry , Hydrazones/chemistry , Prion Proteins/drug effects , Pyridines/chemistry , Chelating Agents/chemical synthesis , Humans , Hydrazones/chemical synthesis , Ligands , Methionine/chemistry , Mutation , Oxidation-Reduction , Prion Proteins/chemistry , Prion Proteins/genetics , Pyridines/chemical synthesisABSTRACT
With the increasing life expectancy of the world's population, neurodegenerative diseases, such as Alzheimer's disease (AD), will become a much more relevant public health issue. This fact, coupled with the lack of efficacy of the available treatments, has been driving research directed to the development of new drugs for this pathology. Metal-protein attenuating compounds (MPACs) constitute a promising class of agents with potential application on the treatment of neurodegenerative diseases, such as AD. Currently, most MPACs are based on 8-hydroxyquinoline. Recently, our research group has described the hybrid aroylhydrazone containing the 8-hydroxyquinoline group INHHQ as a promising MPAC. By studying the known structure-related ligand HPCIH, which does not contain the phenol moiety, as a simplified chemical model for INHHQ, we aimed to clarify the real impact of the aroylhydrazone group for the MPAC activity of a compound with potential anti-Alzheimer's activity. The present work describes a detailed solution and solid-state study of the coordination of HPCIH with Zn2+ ions, as well as its in vitro binding-ability towards this metal in the presence of the Aß(1-40) peptide. Similar to INHHQ, HPCIH is able to efficiently compete with Aß(1-40) for Zn2+ ions, performing as expected for an MPAC. The similarity between the behaviors of both ligands is remarkable. Taken together, the data presented herein point to aroylhydrazones, such as the compounds HPCIH and the previously published INHHQ, as encouraging MPACs for the treatment of AD.
Subject(s)
Hydrazones/chemistry , Nootropic Agents/chemistry , Pyridines/chemistry , Zinc/chemistry , Alzheimer Disease/drug therapy , Amyloid beta-Peptides/metabolism , Coordination Complexes/chemical synthesis , Coordination Complexes/chemistry , Coordination Complexes/metabolism , Hydrazones/chemical synthesis , Hydrazones/metabolism , Ligands , Molecular Structure , Nootropic Agents/chemical synthesis , Nootropic Agents/metabolism , Peptide Fragments/metabolism , Proof of Concept Study , Protein Binding , Pyridines/chemical synthesis , Pyridines/metabolism , Zinc/metabolismABSTRACT
Aroylhydrazones are compounds formed from the condensation of an acylhydrazine and an aldehyde. These compounds exhibit dynamic reversible properties such as isomerization photochemically and thermally activated, hydrazine substitution and coordination to metallic centers. All these together represent systems with multiple dynamics suitable for information storage devices and for the design of molecular photoswitches.
Las aroilhidrazonas son compuestos formados a partir de la condensación de una acilhidrazina y un aldehído. Estos compuestos presentan propiedades dinámicas reversibles tales como la isomerización activada térmica y fotoquímicamente, la sustitución de hidracina y la coordinación con centros metálicos. Todas estas representan sistemas con dinámicas múltiples apropiadas para dispositivos de almacenamiento de información y para el diseño de foto-interruptores moleculares.
Aroilhidrazonas são compostos formados a partir da condensação de uma acilhidrazina e um aldeído. Estes compostos apresentam propriedades reversíveis dinâmicas, como isomerização fotoquímica e termicamente ativada, substituição de hidrazina e coordenação de centros metálicos. Todos estes em conjunto representam sistemas com múl350 Revista Colombiana de Química, Volumen 41, nro. 3 de 2012 tiplas dinâmicas adequadas para dispositivos de armazenamento de informações e para o desenho de fotodispositivos moleculares.